These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 13428204)

  • 1. [Differential influencing of analgesic and central stimulant effects of morphine by central depressant drugs].
    TRIPOD J; GROSS F
    Helv Physiol Pharmacol Acta; 1957; 15(1):105-15. PubMed ID: 13428204
    [No Abstract]   [Full Text] [Related]  

  • 2. [Studies on a biological radiation protection. XXI. Further studies on the effect of central stimulant and depressant drugs on radiation sensitivity in animals].
    LANGENDORFF M; MELCHING HJ; LANGENDORFF H; KOCH R; JAQUES R
    Strahlentherapie; 1957 Nov; 104(3):338-44. PubMed ID: 13519313
    [No Abstract]   [Full Text] [Related]  

  • 3. Individual differences. I. Correlation between control locomotor activity and sensitivity to stimulant and depressant drugs.
    IRWIN S; SLABOK M; THOMAS G
    J Pharmacol Exp Ther; 1958 Jul; 123(3):206-11. PubMed ID: 13564395
    [No Abstract]   [Full Text] [Related]  

  • 4. Central nervous system depressant effects of some indolylethylpyridines.
    MIRSKY JH; WHITE HD; O'DELL TB
    J Pharmacol Exp Ther; 1959 Feb; 125(2):122-7. PubMed ID: 13631611
    [No Abstract]   [Full Text] [Related]  

  • 5. Peripheral versus central antinociceptive actions of 6-amino acid-substituted derivatives of 14-O-methyloxymorphone in acute and inflammatory pain in the rat.
    Fürst S; Riba P; Friedmann T; Tímar J; Al-Khrasani M; Obara I; Makuch W; Spetea M; Schütz J; Przewlocki R; Przewlocka B; Schmidhammer H
    J Pharmacol Exp Ther; 2005 Feb; 312(2):609-18. PubMed ID: 15383636
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is endogenous opioid system involved in non-opioid analgesics tolerance?
    Tsiklauri N; Gurtskaia G; Tsagareli M
    Georgian Med News; 2006 Aug; (137):121-5. PubMed ID: 16980767
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The depressant action of ethyl trichloramate on the central nervous system.
    CHEN G; ENSOR CR; BOHNER B
    J Pharmacol Exp Ther; 1957 Sep; 121(1):136-43. PubMed ID: 13481836
    [No Abstract]   [Full Text] [Related]  

  • 8. 2-Dimethylaminoethanol as a central nervous system stimulant; one aspect of the pharmacology of reserpine.
    MURPHREE HB; JENNEY EH; PFEIFFER CC
    Res Publ Assoc Res Nerv Ment Dis; 1959; 37():204-17. PubMed ID: 13646049
    [No Abstract]   [Full Text] [Related]  

  • 9. The pharmacological effects of Salvia species on the central nervous system.
    Imanshahidi M; Hosseinzadeh H
    Phytother Res; 2006 Jun; 20(6):427-37. PubMed ID: 16619340
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The central depressant profile of some substituted methathiazanones.
    GESLER RM; SURREY AR
    J Pharmacol Exp Ther; 1958 Apr; 122(4):517-24. PubMed ID: 13539780
    [No Abstract]   [Full Text] [Related]  

  • 11. [Influence of morphine, N-allyl-3-hydroxymorphinan and reserpine individually and in combination on the function and metabolism of the central nervous system of white mice].
    LEUSCHNER F; HEIM F; STEINWAND I
    Arzneimittelforschung; 1958 Oct; 8(10):651-5. PubMed ID: 13607290
    [No Abstract]   [Full Text] [Related]  

  • 12. A comparative quantitative study of the central depressant effect of seven clinically used phenothiazine derivatives.
    SANDBERG F
    Arzneimittelforschung; 1959 Apr; 9(4):203-6. PubMed ID: 13651036
    [No Abstract]   [Full Text] [Related]  

  • 13. The effects of tryptamine on the central nervous system, including a pharmacological procedure for the evaluation of iproniazidlike drugs.
    TEDESCHI DH; TEDESCHI RE; FELLOWS EJ
    J Pharmacol Exp Ther; 1959 Jul; 126(3):223-32. PubMed ID: 13673372
    [No Abstract]   [Full Text] [Related]  

  • 14. The interrelationships among the central, peripheral and anticholinesterase effects of some morphinan derivatives.
    YOUNG DC; PLOEG RA; FEATHERSTONE RM; GROSS EG
    J Pharmacol Exp Ther; 1955 May; 114(1):33-7. PubMed ID: 14392568
    [No Abstract]   [Full Text] [Related]  

  • 15. [A hallucinogenic agent from the morphinan group].
    SCHULTZE-GORLITZ F
    Nervenarzt; 1959 Jun; 30(6):256-62. PubMed ID: 13674500
    [No Abstract]   [Full Text] [Related]  

  • 16. [Pharmacodynamic principles of specific action of drugs on the central nervous system].
    NAESS K
    Nord Med; 1957 Jun; 57(24):849-52. PubMed ID: 13452144
    [No Abstract]   [Full Text] [Related]  

  • 17. Melatonin reverses the expression of morphine-induced conditioned place preference through its receptors within central nervous system in mice.
    Han J; Xu Y; Yu CX; Shen J; Wei YM
    Eur J Pharmacol; 2008 Oct; 594(1-3):125-31. PubMed ID: 18706407
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effect of some drugs affecting the central nervous system on thyroxinaccelerated metamorphosis of Rana temporaria].
    TATERKA-SEILER W
    Arzneimittelforschung; 1958 May; 8(5):304-5. PubMed ID: 13535386
    [No Abstract]   [Full Text] [Related]  

  • 19. [Changes of the immuno-biological reactions after the effect of drugs on the central nervous system].
    NAUMANN G; WILDE J
    Zentralbl Bakteriol Orig; 1957 Nov; 170(1-5):347-8. PubMed ID: 13531704
    [No Abstract]   [Full Text] [Related]  

  • 20. [Paper chromatographic identification of pipradrol, azacyclonol & other drugs effecting the central nervous system].
    DUMONT C; BOISSIER JR
    Ann Pharm Fr; 1958 Apr; 16(4):256-60. PubMed ID: 13583715
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.